Morphine-induced conditioned place preference and associated behavioural plasticity in HIV-1 transgenic rats

International Journal of Clinical and Experimental Medicine

Volumn 5, Issue 2, 2012, Pages 105-123

  Homji, Natasha F ^a   Vigorito, Michael ^a   Chang, Sulie L ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

Behavioural plasticity; Conditioned place preference (CPP) test; HIV 1Tg rat; Morphine; Mu opioid receptor

Indexed keywords

MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL PLASTICITY; CONDITIONING; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FOOTSHOCK; HABITUATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MORPHINE ADDICTION; NERVE CELL PLASTICITY; NONHUMAN; PLACE PREFERENCE; RAT; REINFORCEMENT; TRANSGENIC RAT;

EID: 84859987182     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Hales TG. Arresting the development of morphine tolerance and dependence. Br J Anaesth 2011; 107: 653-655.
2. Banerjee A, Strazza M, Wigdahl B, Pirrone V, Meucci O and Nonnemacher MR. Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropa-thogenesis. J Neurovirol 2011; 17: 291-302.
3. Steffen T, Blattler R, Gutzwiller F and Zwahlen M. HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme. Eur J Public Health 2001; 11: 425-430.
4. Beyrer C. HIV epidemiology update and transmission factors: risks and risk contexts--16th International AIDS Conference epidemiology plenary. Clin Infect Dis 2007; 44: 981-987.
5. Shetty P. Nora Volkow--challenging the myths about drug addiction. Lancet 2011; 378: 477.
6. Koulierakis G, Gnardellis C, Agrafiotis D and Power KG. HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction 2000; 95: 1207-1216.
7. Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Jr., Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O'Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M and Bryant J. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 2001; 98: 9271-9276.
8. Peng J, Vigorito M, Liu X, Zhou D, Wu X and Chang SL. The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuro-immunol 2010; 218: 94-101.
9. Chang SL, Beltran JA and Swarup S. Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model. J Virol 2007; 81: 8406-8411.
10. Lund AK, Lucero J, Herbert L, Liu Y and Naik JS. Human immunodeficiency virus- transgenic rats exhibit pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2011; 301: L315-326.
11. Basselin M, Ramadan E, Igarashi M, Chang L, Chen M, Kraft AD, Harry GJ and Rapoport SI. Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats. J Cereb Blood Flow Metab 2011; 31: 486-493.
12. Vigorito M, LaShomb AL and Chang SL. Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2007; 2: 319-328.
13. Lashomb AL, Vigorito M and Chang SL. Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 2009; 15: 14-24.
14. Chang SL and Connaghan KP. Behavioral and Molecular Evidence for a Feedback Interaction Between Morphine and HIV-1 Viral Proteins. J Neuroimmune Pharmacol (in press) 2012.
15. Liu X, Chang L, Vigorito M, Kass M, Li H and Chang SL. Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 trans-genic rat. J Neuroimmune Pharmacol 2009; 4: 309-316.
16. Midde NM, Gomez AM, Harrod SB and Zhu J. Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitiza-tion and alter mesocorticolimbic ERK and CREB signaling in rats. Pharmacol Biochem Behav 2011; 98: 587-597.
17. Fowler CJ and Fraser GL. Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments. Neurochem Int 1994; 24: 401-426.
18. Chang SL, Vigorito M. Role of HIV-1 infection in addictive behavior: A study of a HIV-1 Transgenic Rat Model. American Jornal of Infectious Diseases 2006; 2: 98-106.
19. Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997; 9: 482-497.
20. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005; 162: 1403-1413.
21. Shalev U, Grimm JW and Shaham Y. Neurobiol-ogy of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 2002; 54: 1-42.
22. Kalivas PW. Predisposition to addiction: pharma-cokinetics, pharmacodynamics, and brain circuitry. Am J Psychiatry 2003; 160: 1-2.
23. Tzschentke TM. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 1998; 56: 613-672.
24. Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007; 12: 227-462.
25. Rutten K vdKE, De Vry J, Tzchentke TM. Critical evaluation of the use of extinction paradigms for the assessment of opiod-induced conditioned place preference in rats. Pharmacology 2011; 87: 286-296.
26. Donovan B, Padin-Rivera E and Kowaliw S. Transcend: initial outcomes from a posttrau-matic stress disorder/substance abuse treatment program. J Trauma Stress 2001; 14: 757-772.
27. Ouimette P, Coolhart D, Funderburk JS, Wade M and Brown PJ. Precipitants of first substance use in recently abstinent substance use disorder patients with PTSD. Addict Behav 2007; 32: 1719-1727.
28. Dewart T, Frank B and Schmeidler J. The impact of 9/11 on patients in New York City's substance abuse treatment programs. Am J Drug Alcohol Abuse 2006; 32: 665-672.
29. Leyton M, Stewart J. Preexposure to foot-shock sensitizes the locomotor response to subsequent systemic morphine and intra-nucleus ac-cumbens amphetamine. Pharmacol Biochem Behav 1990; 37: 303-310.
30. Wang B, Luo F, Zhang WT and Han JS. Stress or drug priming induces reinstatement of extinguished conditioned place preference. Neurore-port 2000; 11: 2781-2784.
31. Gagin R, Kook N, Cohen E and Shavit Y. Prenatal morphine enhances morphine-conditioned place preference in adult rats. Pharmacol Biochem Behav 1997; 58: 525-528.
32. Davis CM, Roma PG, Dominguez JM and Riley AL. Morphine-induced place conditioning in Fischer and Lewis rats: acquisition and dose-response in a fully biased procedure. Pharmacol Biochem Behav 2007; 86: 516-523.
33. Grakalic I, Schindler CW, Baumann MH, Rice KC and Riley AL. Effects of stress modulation on morphine-induced conditioned place preferences and plasma corticosterone levels in Fischer, Lewis, and Sprague-Dawley rat strains. Psychopharmacology (Berl) 2006; 189: 277-286.
34. Roma PG, Riley AL. Apparatus bias and the use of light and texture in place conditioning. Pharmacology, Biochemistry and Behavior 2005; 82: 163-169.
35. Bevins RA, McPhee JE, Ranhut AS and Ayres JJB. One-trial context fear conditioning with immediate shock: The role of transport and contextual cues. Animal Learning & Behavior 2000; 28: 162-171.
36. Reid LD, Marglin SH, Mattie ME and Hubbell CL. Measuring morphine's capacity to establish a place preference. Pharmacol Biochem Behav 1989; 33: 765-775.
37. Drucker DB, Ackroff K and Sclafani A. Nutrient-conditioned flavor preference and acceptance in rats: effects of deprivation state and nonrein-forcement. Physiol Behav 1994; 56: 701-707.
38. Elizalde G, Sclafani A. Flavor preferences conditioned by intragastric polycose infusions: a detailed analysis using an electronic esophagus preparation. Physiol Behav 1990; 47: 63-77.
39. Baeyens F, De Houwer J. Evaluative conditioning is a qualitatively distinct form of classical conditioning: a reply to Davey (1994). Behav Res Ther 1995; 33: 825-831.
40. De Houwer J, Thomas S and Baeyens F. Associative learning of likes and dislikes: a review of 25 years of research on human evaluative conditioning. Psychol Bull 2001; 127: 853-869.
41. Myers KM, Carlezon WA, Jr. Extinction of drug-and withdrawal-paired cues in animal models: relevance to the treatment of addiction. Neuro-sci Biobehav Rev 2010; 35: 285-302.
42. Vezina P, Stewart J. Conditioned locomotion and place preference elicited by tactile cues paired exclusively with morphine in an open field. Psy-chopharmacology (Berl) 1987; 91: 375-380.
43. Crombag HS, Dickson M, Dinenna M, Johnson AW, Perin MS, Holland PC, Baraban JM and Reti IM. Narp deletion blocks extinction of morphine place preference conditioning. Neuropsycho-pharmacology 2009; 34: 857-866.
44. Chang S, Connaghan K. Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins. J Neuroim-mune Pharmacol 2011.
45. O'Brien CP. A range of research-based pharma-cotherapies for addiction. Science 1997; 278: 66-70.
46. Aguilar MA, Rodriguez-Arias M and Minarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 2009; 59: 253-277.
47. Shaham Y, Shalev U, Lu L, De Wit H and Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psy-chopharmacology (Berl) 2003; 168: 3-20.
48. Chang SLaMK. Transgenic rodent models. In: Howard E. Gendelman IG, Ian Paul Everall, Stuart A. Lipton and Susan Swindells (Eds.) editors. The Neurology of AIDS. New York.: Oxford University Press Inc.; 2010. p.
49. Bossert JM, Ghitza UE, Lu L, Epstein DH and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol 2005; 526: 36-50.
50. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 2000; 25: 125-136.
51. Shaham Y, Erb S and Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev 2000; 33: 13-33.
52. Erb S SY, Stewart J. Stress-induced relapse to drug seeking in the rat: role of the bed nucleus of the stria terminalis and anygdala. Stress 2001; 4: 289-303.
53. Stewart J. Stress and relapse to drug seeking: studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability. Am J Addict 2003; 12: 1-17.
54. Tull MT, Trotman A, Duplinsky MS, Reynolds EK, Daughters SB, Potenza MN and Lejuez CW. The effect of posttraumatic stress disorder on risk-taking propensity among crack/cocaine users in residential substance abuse treatment. Depress Anxiety 2009; 26: 1158-1164.
55. Back SE, Dansky BS, Carroll KM, Foa EB and Brady KT. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: description of procedures. J Subst Abuse Treat 2001; 21: 35-45.
56. Demas P, Schoenbaum EE, Wills TA, Doll LS and Klein RS. Stress, coping, and attitudes toward HIV treatment in injecting drug users: a qualitative study. AIDS Educ Prev 1995; 7: 429-442.
57. Rotheram-Borus MJ, Rosario M, Reid H and Koopman C. Predicting patterns of sexual acts among homosexual and bisexual youths. Am J Psychiatry 1995; 152: 588-595.